A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms COMPEL
- Sponsors Allergan
- 28 Jun 2018 According to Allergan Media release, data from this trial will be presented at the American Headache Society's 60th Annual Scientific Meeting.
- 27 Apr 2018 Results of a subanalysis assessing the effects of onabotulinumtoxinA prevention on comorbid sleep disturbances and fatigue symptoms, presented at the 70th Annual Meeting of the American Academy of Neurology.
- 27 Apr 2018 Results of psychiatric comorbidities responder analysis (anxiety and depression) in patients with chronic migraine, presented at the 70th Annual Meeting of the American Academy of Neurology.